Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 191 results found. Search for [ Zydus coronavirus vaccine ]

Results 60 to 80 of 191
BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 28, 2020
The government is going to assess efficacy data of all concerned companies (working on COVID-19 vaccines) before inking a purchase contract with them and will buy vaccines at least for essential workers


BusinessToday.In
September 24, 2020
India Stock Market Highlights Today: All Sensex components were in the red with M&M, Bajaj Finance, IndusInd Bank, Maruti, Axis Bank, Bajaj Finserv and ICICI Bank shedding up to 33%.


BusinessToday.In
September 22, 2020
Gagandeep Kang, professor of microbiology at Christian Medical College said that by year-end, data on which vaccine candidate is working and which not will be made available


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 13, 2020
Union Health Minister Harsh Vardhan on Sunday said that he will be the first person to take COVID-19 vaccine so as to dispel the \"trust deficit\" around the same


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


PB Jayakumar
September 9, 2020
Serum has also started manufacturing the vaccine, targeting to use in India and 92 other countries upon completion of trials and regulatory clearances


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


BusinessToday.In
August 23, 2020
Initially, the ICMR vaccine portal will disseminate information on coronavirus vaccine in India. However, with time, data available for all the vaccines will be added to the portal


PB Jayakumar
August 22, 2020
Centre has sought 68 crore doses for 130 crore Indian citizens from Serum Institute by June, next year


BusinessToday.In
August 21, 2020
Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19


BusinessToday.In
August 19, 2020
Coronavirus vaccine news update: Oxford vaccine could be the first antidote to be released in India. Bharat Biotech's COVAXIN and Zydus Cadila's ZyCoV-D are in initial stages of trials


BusinessToday.In
New Delhi, August 19, 2020
COVID-19 pandemic: WHO lambasts 'vaccine nationalism' in last-resort attempt against hoardingNations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. The WHO has an Aug. 31 deadline for wealthier nations to join the \"COVAX Global Vaccines Facility\" for sharing vaccine hopefuls with developing countries...


BusinessToday.In
August 18, 2020
Oxford vaccine news update: The government had formed a coronavirus vaccine expert committee that held discussions on the distribution plans of the vaccine. The trials would be conducted across 10 centres at first


BusinessToday.In
August 17, 2020
Last month, the medical journal Lancet wrote that the Phase-2 clinical trial of CanSino Biologics' adenovirus vector vaccine or Ad5-nCoV was safe and induced immune response


BusinessToday.In
August 15, 2020
Independence day: 'Today, in India, not one or two but three vaccines are in the stage of testing. As soon as there is a green signal from scientists, the country is prepared to produce it in large numbers,' PM Modi said


Joe C Mathew
August 14, 2020
Coronavirus vaccine news update: India's own research institution, the Indian Council of Medical Research (ICMR) is on record for its push to cut down red tapism and accelerate the development of COVID-19 vaccines


PAGES 4 OF 10  12345